Therapeutic portfolio development for the treatment of chronic inflammation based on exosomes enriched with active substances by mechanoporation and produced on a large scale using a new-generation technology on a 3D matrix in fixed-bed bioreactors. ConvEyXo, a preclinical-stage biotech, aims to revolutionise access to exosome-based treatments through innovative technology platforms….
An early stage start-up aiming at developing new technologies focused on heart and vascular diseases that increase efficacy while reducing invasiveness. CorQuest MedTech srl was created in 2019 and is actively working on a first project targeting mitral valve. Our main activities are directly related to our pipeline of cardiac…